IL1β siCon siRNF20 1 siRNF20 3 siRNF20 3 siRNF20 2 siRNF20 2 siRNF20 1 siCon MCF10A cells were transfected for 48 hours with siRNA targeted against either RNF20 or LacZ as control, and then treated with 10ng/ml TNF-α for different durations. Global H2Bub1 and H2B levels were monitored by Western blot analysis. Similar results were obtained in nine independent experiments.
B.
MCF10A cells were treated with TNF-α for the indicated durations, harvested and subjected to chromatin immunoprecipitation (ChIP) with H2B and H2Bub1 antibodies. Precipitated DNA was subjected to qRT-PCR analysis with primers corresponding to the promoter κB site (B) and the first or second exons of the IL8, CXCL1 and IL6 genes, as well as a low H2Bub1 low-transcribed region (con). I. MCF10A cells were transfected for 48 hours with 3 different single siRNA oligonucleotide targeted against RNF20 or with LacZ siRNA (siCon) as control, and then treated with 10ng/ml TNF-α for cytokine mRNAs were quantified by qRT-PCR and normalized to GAPDH mRNA in the same sample.
J. MCF10A cells were treated with TNF-α for the indicated durations, harvested and subjected to chromatin immunoprecipitation (ChIP) with H3 and H3K9me3 antibodies. Precipitated DNA was subjected to qRT-PCR analysis with primers spanning the κB site of the IL8, CXCL1 and IL6 genes.
H3K9me3 ChIP values were normalized to H3 values. Error bars = SD. Similar results were obtained in three independent experiments.
Figure S2-related to figure 2. RNF20 knockdown increases NF-B-dependent cytokine gene expression but does not affect p65 and p50 expression, IκB degradation or p65 localization
A. MCF10A cells were transfected for 48 hours with siRNA targeted against either RNF20, p65, RNF20 plus p65 (dKD) or LacZ as control, and then treated with 10ng/ml TNF-α for different durations. B. MCF10A cells were transfected for 48 hours with siRNA targeted against either RNF20, p50, RNF20 plus p50 (dKD) or LacZ as control, and then treated and analyzed for IL8, Cxcl1 and p50 mRNA expression as in (A). Error bars = SD. Similar results were obtained in four independent experiments.
C. MCF10A cells were transfected for 48 hours with siRNA targeted against RNF20 or LacZ as control, and then treated with 10 ng/ml TNF-α for 30 minutes. Cell extracts were subjected to Western blot analysis with the indicated antibodies. Similar results were obtained in three independent experiments. D. MCF10A cells were transfected with the indicated siRNA oligonucleotides, treated with 10ng/ml TNF-α for the indicated time periods, fixed and stained with p65 (green) or RNF20 (red) specific antibodies or with DAPI. Similar results were obtained in three independent experiments.
Figure S3-related to figure 3. Analysis of RNF20 and cytokine expression in YAMC cells, small intestine organoids, peritoneal inflammatory leukocytes and bone marrow-derived macrophages
A. YAMC cells were transfected with siRNA targeted against RNF20 or LacZ as control. 48 hours later cells were treated with 10 ng/ml TNF-α for 1 hour or left untreated (0). RNF20 mRNA was quantified by qRT-PCR. Values were normalized to β-actin mRNA in the same sample. Error bars = SD. Similar results were obtained in five independent experiments.
B.
Lungs of either RNF20+/-or WT mice were homogenized and proteins were extracted and subjected to Western blot analysis for RNF20, GAPDH, H2Bub1 and total H2B. The expected size of the truncated RNF20 protein is around 97kD.
C.
Small intestine organoids were treated with 10 ng/ml TNF-α for different durations. F. Bone marrow-derived macrophages from WT and RNF20+/-mice were prepared as described (Foster, Hargreaves et al. 2007 ) and treated with 10 ng/ml TNF-α for 30 minutes. mRNA levels of the G.
Colons of either RNF20+/-or WT mice were homogenized and RNA was extracted as described in supplemental experimental procedures. RNF20 mRNA levels were determined by qRT-PCR, employing primers derived from exon 18 of the RNF20 gene, and normalized to β-actin mRNA in the same sample. Error bars = SE.
H. RNA extracted from the lungs of WT and RNF20+/-mice was subjected to qRT-PCR analysis of RNF20 mRNA, employing primers derived from exon 18 of the RNF20 gene. In parallel, proteins were extracted from another section of the same lung and subjected to Western blot analysis for H2Bub1;
H2Bub1 band intensities were normalized to H2B in the same sample. For each mouse, normalized
H2Bub1 level was plotted against the corresponding RNF20 mRNA level. Spearman correlation coefficient =0.77, **=p-value<0.01.
I.
Lung RNF20 mRNA was quantified at day 7 as in (F). In parallel, the colons of the same mice were incubated in PBS for 24 hours at 37 o C, and the supernatant was collected for IFN-γ secretion analysis by ELISA. Levels of secreted IFN-γ were then plotted against RNF20 mRNA. Spearman correlation coefficient =-0.70, **=p-value<0.01.
J.
MIP2 mRNA in the colons of individual mice was quantified at day 26, and values were plotted against those of lung RNF20 mRNA in the same mice. Spearman correlation coefficient =-0.42, *=pvalue <0.05.
K.
Lung RNF20 mRNA was quantified at day 180 as in (F). Colon lengths were measured in parallel, and plotted against RNF20 mRNA. Spearman correlation coefficient=0.67, *=p-value<0.05.
L.
Lung RNF20 mRNA was quantified at day 180 as in (F). Individual mouse spleen weights were plotted against lung RNF20 mRNA in the same mouse. Spearman correlation coefficient=-0.746, **=p-value<0.01. StepOnePlus instrument (Applied Biosystems). For hnRNA analysis, primers spanning both exonic and intronic regions were used, thus allowing the analysis of nascent, non-spliced RNA, which corresponds to primary transcript.
SDS-PAGE and Western blotting
For protein extraction, cells were lysed in NP40 lysis buffer (150mM NaCl, 50mM Tris pH8, 1% NP40) freshly supplemented with protease inhibitor mix (Sigma-Aldrich, USA). Lysates were centrifuged at 14,000 RPM for 10 minutes at 4°C, and the soluble fraction was taken for further analysis. Protein concentration evaluation was done with the BCA kit (Thermo Fisher Scientific, Chicago, USA) according to the manufacturer's protocol.
Next, protein sample buffer (3% SDS, 10% glycerol, 5% β-mercaptoethanol, 62mM Tris pH6.8) was added and aliquots containing equal amounts of total protein were heated at 95 0 C for 5 minutes and vortexed vigorously three times, followed by centrifugation at 14,000 RPM. Supernatants were subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) on a 12.5% gel, followed by transfer to a nitrocellulose membrane. Membranes were blocked in 5% milk for 1 hour, incubated with antibodies overnight at 4 0 C, washed three times in PBST (0.05% Tween-20 in PBS) and incubated for 1 hour with horseradish-peroxidase (HRP)-conjugated IgG, followed by 3 washes with PBS-T. Finally, membranes were incubated for 1 minute with ECL mix (GE healthcare, Little Chalfont, UK).
For chromatin bound/unbound fractions cells were harvested in buffer A (100mM NaCl, 300mM sucrose, 3mM
MgCl2, 10mM PIPES pH6.8, 1mM EGTA, 0.2% triton x-100), followed by a 3 minute 1500 rpm spin.
Supernatants were collected as soluble unbound fraction, while pellets were suspended in buffer B (50mM NaCl, 300mM sucrose, 3mM MgCl2, 10mM PIPES pH6.8, 1mM EGTA) supplemented with DNase I (final concentration = 0.5 U/µl) and incubated for 30 minutes at 37°C.
Chromatin immunoprecipitation
For H2Bub1, H2B, H3K9me3, H3 and Pol II phospho-ser 5 ChIP, cells were fixed by adding 0.1 volume of an 11% formaldehyde solution directly to the medium for 10 minutes at room temperature, followed by addition of 0.06 volumes of 2.5M glycine. Next, cells were washed twice with PBS, harvested and pelleted at 3,000 RPM.
To extract chromatin, cells were resuspended in 1ml of cell lysis buffer (50mM PIPES, 85mM KCl, 0.5% NP-40); nuclei were pelleted by centrifugation at 4,000 RPM at 4 0 C, and resuspended in 100μl of nuclei lysis buffer (50mM Tris-Cl, 10mM EDTA, 1% SDS). Next, samples were diluted 1:4 in dilution buffer (0.01% SDS, 1.1% Proteinase K (20 g each), 40mM Tris-HCl pH6.5, and 10mM EDTA, and DNA was purified as above.
For Re-ChIP experiments 25µl of ReChIP buffer (Dilution Buffer with 10mM DTT) was added to washed beads and incubated at 37°C for 30 minutes. The sample was then diluted 40 times in dilution buffer and subjected to immunoprecipitation, washes and elution as above.
For ChIP of mouse colons, epithelial cells were isolated from the colon as described ) and ChIP was performed as above.
Immunofluorescence staining
For immunofluorescence staining cells were plated on 12mm coverslips and fixed with ice-cold methanol for 1 minute at room temperature. Next, coverslips were washed three times with PBS. Subsequently, coverslips were blocked with 10% FBS in PBS for 30 minutes, incubated for 1 hour with primary antibody in washing buffer (PBS with 2% FBS), and washed 3 times with washing buffer followed by 30 minutes incubation with secondary antibody or 5mg/ml DAPI (Sigma-Aldrich). Following further washing with washing buffer, coverslips were mounted on slides for microscopy.
Cytokine analysis:
Peritoneal leukocytes were plated or colon specimens were harvested and washed in sterile 20mM PBS, pH7.4, and then cut longitudinally and horizontally into 1cm fragments. Colon fragments were spread into 6-well dishes and incubated for 24 hours with 1ml PBS. Levels of secreted Interferon-γ (IFN-γ) and TNF-α in the supernatants were measured by an enzyme-linked immunosorbent assay (ELISA) (Biolegend, San Diego, USA) according to the manufacturer's instructions.
Antibodies:
The following primary antibodies were used for Western blot analysis and ChIP: anti-H2B (07-371, Millipore), anti-RNF20 (ab32639, Abcam), anti p50 (ab7971, Abcam), anti p65 (sc372, Santa Cruz), anti IκB (ab7217, Abcam), anti β-tubulin (T7816, Sigma-Aldrich), anti H3K9me3 (ab8898, Abcam), anti H3 (ab1791, Abcam),
anti Pol II phospho ser5 (ab5131, Abcam). Anti H2Bub1 was described before ). co-incubation experiments and RNA analysis, MDSCs were isolated from mouse spleens by MACS cell separation using anti-Gr1 antibodies with a magnetic column separation system (Miltenyi Biotec) as previously described . For functional analysis, MDSCs were co-incubated with naïve splenic T cells for 20h as previously described .
Generation of RNF20+/-mice

Immunohistochemistry
For IHC analysis the following antibodies were employed: anti-p65/RelA (C-20, sc-372, Santa Cruz; 1:100), anti-p65/RelA (Ab-1, RB-1638-P, Thermo Scientific/Pierce; 1:100), anti-p50/p105 (E381, ab32360, Abcam), anti-phospho-histone H2AX (Ser139, 05-636, Millipore; 1:1000), anti-p53 (NCL-p53-CMp, Novocastra, 1:400), anti-p21 (F-5, sc-6246, Santa Cruz, 1:200), anti-histone H2B (ab52484, Abcam; 1:1500), anti-ubiquityl-histone H2B (56, 05-1312, Millipore; 1:1500), anti-CD3 (ab5690, Abcam; 1:400), anti-F4/80 (c1:A3, MCA497G, Serotec; 1:100), anti-CD206 (ab64693, Abcam; 1:1500), anti-CD11b (ab75476, Abcam, 1:500) and anti-Gr1 (RB6-8C5, ab25377, Abcam; 1:50). IHC was performed on paraffin-embedded tissues. Unmasking of the antigen retrieval was performed by heat-mediated antigen retrieval method in 10mM citric acid (pH6.0). For anti-p65/RelA, anti-p50/p105, anti-phospho-histone H2AX, anti-histone H2B, anti-ubiquityl-histone H2B, analysis the UltraVision LP Detection System was employed (#TL-060-HD, Thermo Scientific, Bioanalytica, Greece) according to the manufacturer's instructions. For anti-p53, anti-p21, anti-CD3 (Abcam), anti-CD45R/B220, anti-F4/80, anti-CD206, anti-CD11b and anti-Gr1 the indirect streptavidin-biotin-hyperoxidase method was employed. Sections were incubated with 3% hydrogen peroxide to quench endogenous peroxidase. Prior to the addition of the primary antibody all sections were incubated with a streptavidin and a biotin solution for 15 minutes each time, in order to block endogenous biotin employing the Streptavidin/Biotin kit (#SP2002) from Vector.
Incubation with the secondary antibody was performed using a biotin-conjugated antibody at a 1:200 dilution for 30 minutes. The next step comprised 30 minutes of incubation in Streptavidin HRP Conjugate
